Therapy for Ocular Angiogenesis: Principles and Practice

I: PRINCIPLES 1: Tumor Angiogenesis: Concept Judah Folkman (Reproduction of the Hellen Keller Foundation Lecture 2006) 2: Retinal Neovascularization: Pathophysiology Robert Frank 3: Choroidal Neovascularization: Pathophysiology J. Ambati 4: VEGF the Major Player Patricia D'Amore 5: IFG-1 in Angiogenesis Lois Smith 6: Is It All the VEGF? Other Factors John Penn 7: Proteinases and Integrins Alexander Ljubimov and Arup Das 8: Endogenous Inhibitors David Hinton 9: Macular Edema: Molecular Mechanisms Arup Das II: PRACTICE 1: Anti-VEGF Therapies in ARMD in Practice Jeff Heier 2: Novel Anti-VEGF Drugs in ARMD Currently in Trials Quan Nguyen 3: Safety of Anti-VEGF Drugs David Boyer and Thomas Friberg 4: Pharmacokinetics of Anti-VEGF Drugs Karl Casky 5: Anti-VEGF Therapies of Retinal Neovascularization Allen Ho 6: Anti-VEGF Therapies in Diabetic Macular Edema Lloyd Aiello 7: Steroids in ARMD and Macular Edema Jennifer Lim 8: Anti-VEGF Therapies in ROP Antonio Capone 9: Pharmacotherapy in Retinal Vein Occlusions Michael Ip 10: Intravitreal Injection: Technique and Complications Elias Reichel 11: Role of OCT in Management of ARMD and Macular Edema Srinivas Sadda 12: Role of Laser in the Era of Pharmacotherapy Thomas Friberg 13: PDT: Is It an Option? Albert Augustin 14: Combination Therapy: Future Richard Spaide 15: Gene Therapy in Ocular Angiogenesis Rajendra Kumar-Singh 16: Stem Cell Therapy Maria Grant 17: Drug Delivery in Posterior Segment: Challenges Prithvi Mruthyunjaya and Glenn Jaffe 18: Corneal Neovascularization Bala Ambati 19: Neovascular Glaucoma James Tsai 20: Financial Impact of Anti-Angiogenic Therapy George Williams 21: Future of Anti-Angiogenic Therapy Anthony Adamis